source
- Vertex awaits FDA decision on povetacicept for IgA nephropathy, analysts expect approvalVertex Pharmaceuticals is awaiting an FDA ruling this month on its investigational drug povetacicept, being evaluated for the treatment of IgA nephropathy. Analysts, including Myles Minter of Will…
- Beren Therapeutics secures FDA approval for Lembaz to treat infantile-onset Niemann-Pick disease type CBeren Therapeutics announced that the U.S. Food and Drug Administration has approved its drug Lembaz for the treatment of infantile‑onset Niemann‑Pick disease type C, a rare and severe pediatric co…